- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Subaortic and mid-ventricular obstructive hypertrophic cardiomyopathy with an apical Aneurysm: a case report
© Cianciulli et al; licensee BioMed Central Ltd. 2006
Received: 10 February 2006
Accepted: 22 March 2006
Published: 22 March 2006
Most patients with hypertrophic cardiomyopathy (HCM) have asymmetric septal hypertrophy and among them, 25% present dynamic subaortic obstruction. Apical HCM is unusual and mid-ventricular HCM is the most infrequent presentation, but both variants may be associated to an apical aneurysm. An even more rare presentation is the coexistece mid-ventricular and apical HCM. This case is a combination of obstructive HCM with mid-ventricular HCM and an apical aneurysm, which to date, has not been reported in the literature.
The patient is a 49 year-old lady who presents a combination of septal asymmetric hypertrophic cardiomyopathy (HCM) and midventricular HCM, a subaortic gradient of 65 mm Hg and a midventricular gradient of 20 mm Hg, plus an apical aneurysm. Her clinical presentation was an acute myocardial infarction in June 2005. One month after hospital discharge, the electrocardiogram (ECG) showed a right bundle branch block (RBBB) with no Q waves or ST segment elevation. Coronary angiography revealed normal coronary arteries, left ventricular hypertrophy and an apical aneurysm.
This case is a rare example of an asymptomatic patient with subaortic and mid-ventricular hypertrophic cardiomyopathy, who presents a myocardial infarction and normal coronary arteries, and during the course of her disease develops an apical aneurysm.
HCM has a prevalence of 0.2 % (1 in 500) in the general population  and presents with marked clinical polymorphism, given by the extent and degree of hypertrophy of the myocardium involved and by the location and magnitude of the intraventricular gradient. Doppler-echocardiography plays an important role in the diagnosis, identifying the distribution of hypertrophy and the site of intraventricular obstruction.
Most patients with HCM (95%) have asymmetric septal hypertrophy and among them, 25% present with dynamic subaortic obstruction . Apical HCM is unusual and mid-ventricular HCM is the most infrequent presentation, but both variants may be associated to an apical aneurysm. An even more rare presentation is that of coexistent mid-ventricular and apical HCM. This case represents a combination of asymmetric septal and mid-ventricular HCM with an apical aneurysm, which to date, has not been reported in the literature.
The ECG at hospital discharge showed sinus rhythm, right bundle branch block (RBBB) with no Q waves, right ventricular hypertrophy and/or posterior necrosis (Figure 1B). The vectorcardiogram was consistent with apical necrosis (Figure 1C). The chest X-ray showed a mild increase in cardiothoracic index and the lower left arch. The 24-hour Holter showed sinus rhythm, permanent RBBB and 234 monomorphic premature ventricular contractions (PVC's), without complex arrhythmias.
Laboratory tests and serology for Chagas disease were normal.
During follow-up, the patient was treated with beta-blockers and remained clinically stable.
Echocardiogram and left ventriculography of our patient showed an apical aneurysm (although the epicardial coronary arteries were angiographically normal), asymmetric septal and mid-ventricular hypertrophy, a moderate subaortic gradient and a mild mid-ventricular gradient.
Apical infarction is not a rare finding in patients with mid-ventricular HCM. Several reports have shown an association of mid-ventricular and apical HCM with apical aneurysms [3–5]. The mechanisms responsible for an apical infarction are not completely understood, but such patients are known to have normal epicardial coronary arteries, usually present with microvascular dysfunction and a decrease in coronary reserve, attributed to narrowing of the small intramyocardial coronary arteries. The combination of an increase in oxygen demand due to increased ventricular thickness and the decrease in oxygen supply due to a decrease in the capillary network predispose to ischemia. Additionally, the apical chamber is subject to greater and sustained systolic stress due to the high intraventricular gradient.
The apical aneurysm observed in our patient, in the presence of normal epicardial coronary arteries and in the absence of coronary spasm, could be due to microvascular dysfunction and increased stress in the apical chamber, consequent to the combination of subaortic and mid-ventricular obstruction .
To the best of our knowledge, no cases of combined subaortic and mid-ventricular obstructive HCM, associated with apical aneurysm have been described.
Treatment of symptomatic HCM is aimed at reducing the intraventricular gradient which, in most cases, is achieved with beta-blockers and calcium antagonists (diltiazem or verapamil).
Cases of HCM with an apical aneurysm may be complicated by serious ventricular arrhythmias, which usually respond to antiarrhythmic drugs (amiodarone); however, when they are refractory to medical treatment, the insertion of an implantable defibrillator may be warranted , to prevent sudden death. In some patients with an apical aneurysm and very thin walls, the size of the aneurysm may increase rapidly, which entails a high risk of spontaneous rupture and, hence the surgical resection of the aneurysm may be required . On rare occasions, a thrombus may form inside the aneurysm, which may cause embolization  and thus, in such cases, anticoagulation is indicated.
Several reports have shown the association between mid-ventricular and apical HCM and apical aneurysms, but this is the first case presenting a special phenotypic expression of HCM, characterized by a combination of asymmetric septal and mid-ventricular HCM that presents clinically as an infarction with normal coronary arteries and develops an apical aneurysm.
- Maron BJ: Hypertrophic cardiomyopathy: an important global disease. Am J Med. 2004, 116: 63-66.View ArticlePubMedGoogle Scholar
- Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management of hypertrophic cardiomyopathy. N Engl J Med. 1997, 336: 775-85.View ArticlePubMedGoogle Scholar
- Mantica M, Della Bella P, Arena V: Hypertrophic cardiomyopathy with apical aneurysm: a case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia. Heart. 1997, 77: 481-83.View ArticlePubMedPubMed CentralGoogle Scholar
- Inoue T, Sunagawa O, Tohma T, Shinzato Y, Fukiyama K: Apical hypertrophic cardiomyopathy followed by midventricular obstruction and apical aneurysm: a case report. J Cardiol. 1999, 33: 217-22.PubMedGoogle Scholar
- Harada K, Shimizu T, Sugishita Y, Yao A, Suzuki J, Takenaka K, Hirata Y, Nagai R, Takahashi T: Hipertophic cardiomyopathy with midventricular obstruction and apical aneurysm: a case report. Jpn Circ J. 2001, 65: 915-9.View ArticlePubMedGoogle Scholar
- Wigle ED, Rakowski H: Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with small nonobliterated area at the apex of the left ventricle?. J Am Col Cardiol. 1992, 19: 525-26.View ArticleGoogle Scholar
- Maron BJ: Hypertrophic cardiomyopathy. A systematic review. JAMA. 2002, 287: 1308-20.PubMedGoogle Scholar
- Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M: Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003, 42: 288-95.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.